Sen. Hassan: In Letter to Senators, FDA Says It Failed to Follow Up After Media Reports Revealed McKinsey's Potential Conflicts of Interest in Relation to Opioid Crisis
October 28, 2021
October 28, 2021
WASHINGTON, Oct. 28 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
In a letter to Senators, including Maggie Hassan (D-NH), Chuck Grassley (R-IA), and Sheldon Whitehouse (D-RI), the Food and Drug Administration (FDA) said that it did not push for answers after learning from media reports that McKinsey & Company did not reveal potential conflicts of interest to the FDA while they were contracted to work for the agency, which included working simultaneo . . .
In a letter to Senators, including Maggie Hassan (D-NH), Chuck Grassley (R-IA), and Sheldon Whitehouse (D-RI), the Food and Drug Administration (FDA) said that it did not push for answers after learning from media reports that McKinsey & Company did not reveal potential conflicts of interest to the FDA while they were contracted to work for the agency, which included working simultaneo . . .